The Role of N-terminal PRO-Brain Natriuretic Peptide and Echocardiography for Screening Asymptomatic Left Ventricular Dysfunction in a Population at High Risk for Heart Failure. The PROBE-HF Study

Journal of Cardiac Failure

Volumn 15, Issue 5, 2009, Pages 377-384

  Betti, Irene ^a   Castelli, Gabriele ^b   Barchielli, Alessandro ^a   Beligni, Cinzia ^a   Boscherini, Vittorio ^c   De Luca, Leonardo ^d   Messeri, Gianni ^b   Gheorghiade, Mihai ^e   Maisel, Alan ^f   Zuppiroli, Alfredo ^a  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c LEONARDO S P A   (Italy)

^d EUROPEAN HOSPITAL   (Italy)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

diabetes; Natriuretic peptides; systemic hypertension

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POPULATION SURVEILLANCE; PROGNOSIS; PROTEIN PRECURSORS; RISK FACTORS; SINGLE-BLIND METHOD; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 65849236655     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.12.002     Document Type: Article

References (41)

1. Swedberg K.(c.), Cleland J., Dargie H., et al., Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J 26 (2005) 1115-1140
2. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 112 (2005) 1825-1852
3. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327 (1992) 685-691
4. Pfister R., Scholz M., Wielckens K., Erdmann E., and Schneider C.A. Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 6 (2004) 269-273
5. Hobbs F.D.R., Davis R.C., Roalfe A.K., Hare R., Davies M.K., and Kenkre J.E. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 324 (2002) 1-5
6. Richards A.M., Nicholls M.G., Troughton R.W., et al. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 39 (2002) 1182-1188
7. McClure S.J., Caruana L., Davie A.P., Goldthorp S., and McMurray J.J.V. Cohort study of plasma natriuretic peptides for identifying systolic dysfunction in primary care. BMJ 317 (1998) 516-519
8. Nielsen O.W., Hansen J.F., Hilden J., Larsen C.T., and Svanegaard J. Risk assessment of left ventricular dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests. BMJ 320 (2000) 220-224
9. Landray M.J., Lehman R., and Arnold I. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study. BMJ 320 (2000) 985-986
10. Nakamura M., Endo H., Nasu M., Arakawa N., Segawa T., and Hiramori K. Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population. Heart 87 (2002) 131-135
11. McDonagh T.A., Cunningham A.D., Morrison C.E., et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 86 (2001) 21-26
12. Andersson B., and Hall C. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function. J Card Fail 6 (2000) 208-213
13. Maisel A.S., Koon J., Krishnaswamy P., et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 141 (2001) 367-374
14. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC/7 Report. JAMA 289 (2003) 2560-2572
15. Collinson P.O., Barnes S.C., Gaze D.C., Galasko G., Lahiri A., and Senior R. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analyser. Eur J Heart Fail 6 (2004) 365-368
16. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiography 2 (1989) 358-367
17. Wang T.J., Levy D., Benjamin E.J., et al. The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening. Ann Intern Med 138 (2003) 907-916
18. Verdecchia P., Angeli F., Gattobigio R., et al. Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value. Hypertension 45 (2005) 412-418
19. Dei Cas L., Metra M., Nodari S., et al. Prevention and management of chronic heart failure in patients at risk. Am J Cardiol 91 (2003) 10F-17F
20. Annonu A.K., Fattah A.A., Mokhtar M.S., et al. Left ventricular systolic and diastolic functional abnormalities in asymptomatic patients with non-insulin-dependent diabetes mellitus. J Am Soc Echocardiogr 14 (2001) 885-891
21. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association. Task Force on practice guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Bonow RO, Carabello BA. Chatterjee K. J Am Coll Cardiol 48 (2006) e1-e148
22. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Eng J Med 339 (1998) 321-328
23. Cowie M.R., and Mendez G.F. BNP and congestive heart failure. Prog Cardiovasc Dis 44 (2002) 293-321
24. Baughman K.L. B-type natriuretic peptide. A window to the heart. N Eng J Med 347 (2002) 158-159
25. Masson S., Gorini M., Salio M., Lucci D., Latini R., and Maggioni AP on behalf of the IN-CHF Investigators. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. Ital Heart J 1 (2000) 282-288
26. Yamamoto K., Burnett J.C., Bermudez E.A., Jougasaki M., Bailey K.R., and Redfield M.M. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail 6 (2000) 194-200
27. Maisel A. B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure. J Card Fail 7 (2001) 183-193
28. Latini R., Masson S., De Angelis N., and Anand I. Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts. J Card Fail 8 (2002) 288-299
29. Lee S.C., Stevens T.L., Sandberg S.M., et al. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Card Fail 8 (2002) 149-154
30. Wieczorek S.J., Wu A.H.B., Christenson R., et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J 144 (2002) 834-839
31. McDonagh T.A., Holmer S., Raymond I., Luchner A., Hildebrandt P., and Dargie H.J. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail 6 (2004) 269-273
32. Tschöpe C., Mario Kašner M., Westermann D., Gaub R., Polle W.C., and Schultheiss H.P. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 26 (2005) 2277-2284
33. Markham D.W., and de Lemos J.A. Screening for cardiovascular disease using B-type natriuretic peptides: detecting an imbalance of the four humours. Eur Heart J 26 (2005) 2220-2221
34. Troughton R.W., Prior D.L., Pereira J.J., et al. Plasma B-type natriuretic peptide levels in systolic heart failure. Importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 43 (2004) 416-422
35. Nielsen O.W., Kirk V., Bay M., Boesgaard S., and Nielsen H. Value of N-terminal pro brain natriuretic peptide in the elderly: data from the prospective Copenhagen Hospital Heart Failure study (CHHF). Eur J Heart Fail 6 (2004) 275-279
36. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
37. Galasko G.I.W., Lahiri1 A., Barnes S.C., Collinson P., and Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?. Eur Heart J 26 (2005) 2269-2276
38. Aspromonte N., Feola M., Scardovi A.B., et al. Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography. J Cardiovasc Med 7 (2006) 406-413
39. Silver M.A., and Pisano C. High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs. Congest Heart Fail 9 (2003) 127-132
40. Bursi F., Weston S.A., Redfield M.M., et al. Systolic and diastolic heart failure in the community. JAMA 296 (2006) 2209-2216
41. McCullough P.A., and Sandberg K.R. Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med 4 Suppl 4 (2003) S13-S19